Lund-Katz S, Laplaud P M, Phillips M C, Chapman M J
Department of Biochemistry, Allegheny University of the Health Sciences, MCP Hahnemann School of Medicine, Philadelphia, Pennsylvania 19129, USA.
Biochemistry. 1998 Sep 15;37(37):12867-74. doi: 10.1021/bi980828m.
The plasma low-density lipoprotein (LDL) profile in coronary artery disease patients is characterized by a predominance of small, dense LDL. Small, dense LDL exhibit both high susceptibility to oxidation and low binding affinity for the LDL receptor, suggesting that these particles may be of elevated atherogenic potential. Here we examine whether the variation in biological function is due to differences in apo B-100 conformation that alter the interaction with the cellular LDL receptor. The microenvironments (pKa) of Lys residues in apo B-100 in small, dense, intermediate, and light human LDL subspecies have been compared by 13C NMR, and the net surface charge of these particles has been characterized. Relative to the total LDL fraction, small, dense, and light LDL subspecies have a decreased number of pKa 8.9 Lys, while intermediate density LDL has a consistently higher number of pKa 8.9 Lys. It follows that differences in protein conformation, as reflected in the Lys microenvironments, exist in the different LDL subspecies. Electrophoretic mobility measurements revealed that the light LDL subfractions exhibit a surface charge at pH 8.6 that is from -26 to -34e more negative than the intermediate density LDL subfraction. For the small, dense LDL particles the increments in negative charge range from -7 to -17e relative to the intermediate density LDL subfraction. These results suggest that differences in the conformation of apo B-100 and surface charge between LDL subspecies are major determinants of their catabolic fate. The lower number of pKa 8.9 Lys leads to a reduction in binding of small, dense, and light LDL to the cellular LDL receptor and prolongs their plasma residence time, thereby elevating the atherogenicity of these particles. These data support the proposal that the intermediate LDL subspecies constitute the optimal ligand for the LDL receptor among human LDL particle subpopulations.
冠心病患者的血浆低密度脂蛋白(LDL)特征是小而密的LDL占主导。小而密的LDL既具有高氧化敏感性,又对LDL受体的结合亲和力低,这表明这些颗粒可能具有更高的致动脉粥样硬化潜力。在此,我们研究生物学功能的差异是否归因于载脂蛋白B - 100构象的差异,这种差异改变了与细胞LDL受体的相互作用。已通过13C NMR比较了小而密、中等密度和轻密度人LDL亚类中载脂蛋白B - 100中赖氨酸残基的微环境(pKa),并对这些颗粒的净表面电荷进行了表征。相对于总LDL组分,小而密和轻密度LDL亚类中pKa 8.9赖氨酸的数量减少,而中等密度LDL中pKa 8.9赖氨酸的数量始终较高。由此可见,不同LDL亚类中存在蛋白质构象差异,如赖氨酸微环境所反映的那样。电泳迁移率测量显示,轻密度LDL亚组分在pH 8.6时的表面电荷比中等密度LDL亚组分多负26至34e。对于小而密的LDL颗粒,相对于中等密度LDL亚组分,负电荷增加范围为 - 7至 - 17e。这些结果表明,LDL亚类之间载脂蛋白B - 100构象和表面电荷的差异是其分解代谢命运的主要决定因素。pKa 8.9赖氨酸数量较少导致小而密和轻密度LDL与细胞LDL受体的结合减少,并延长其在血浆中的停留时间,从而提高这些颗粒的致动脉粥样硬化性。这些数据支持了以下提议:在人类LDL颗粒亚群中,中等密度LDL亚类构成LDL受体的最佳配体。